12:00 AM
 | 
Jun 18, 2012
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Zogenix, Covidien sales and marketing update

Zogenix and Covidien's Mallinckrodt LLC pharmaceuticals business partnered to co-promote Zogenix's migraine drug Sumavel DosePro sumatriptan injection in the U.S. The deal runs through June 30, 2014, and can be extended by six month increments. Zogenix, which will continue...

Read the full 185 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >